Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 54
Filter
1.
Int J Mol Sci ; 22(16)2021 Aug 18.
Article in English | MEDLINE | ID: mdl-34445607

ABSTRACT

BACKGROUND: Transition metals play a crucial role in brain metabolism: since they exist in different oxidation states they are involved in ROS generation, but they are also co-factors of enzymes in cellular energy metabolism or oxidative defense. METHODS: Paired serum and cerebrospinal fluid (CSF) samples were analyzed for iron, zinc, copper and manganese as well as for speciation using SEC-ICP-DRC-MS. Brain extracts from Mn-exposed rats were additionally analyzed with SEC-ICP-DRC-MS. RESULTS: The concentration patterns of transition metal size fractions were correlated between serum and CSF: Total element concentrations were significantly lower in CSF. Fe-ferritin was decreased in CSF whereas a LMW Fe fraction was relatively increased. The 400-600 kDa Zn fraction and the Cu-ceruloplasmin fraction were decreased in CSF, by contrast the 40-80 kDa fraction, containing Cu- and Zn-albumin, relatively increased. For manganese, the α-2-macroglobulin fraction showed significantly lower concentration in CSF, whereas the citrate Mn fraction was enriched. Results from the rat brain extracts supported the findings from human paired serum and CSF samples. CONCLUSIONS: Transition metals are strictly controlled at neural barriers (NB) of neurologic healthy patients. High molecular weight species are down-concentrated along NB, however, the Mn-citrate fraction seems to be less controlled, which may be problematic under environmental load.


Subject(s)
Brain/metabolism , Chromatography, Gel/methods , Mass Spectrometry/methods , Trace Elements/blood , Trace Elements/cerebrospinal fluid , Adult , Aged , Aged, 80 and over , Animals , Female , Humans , Male , Middle Aged , Rats
2.
Int J Neurosci ; 131(1): 95-101, 2021 Jan.
Article in English | MEDLINE | ID: mdl-32083968

ABSTRACT

Objective: Recent studies have found that selenium (Se) levels were associated with the risk of Parkinson's disease (PD), but the results were contradictory. Therefore, this meta-analysis was conducted to investigate the correlation between Se levels and PD.Methods: PubMed, Embase and Web of Science were searched published up to 28 October 2019. The differences between groups were analyzed by forest plots and results were pooled and assessed using a random-effect model. Standardized mean difference (SMD) and 95% confidence interval (CI) were used to assess the association between Se levels and the risk of PD. Subgroup analysis, meta-regression, and sensitivity analysis were also conducted. Publication bias was estimated using Begg's regression asymmetry test.Results: Finally, 12 articles involving 601 PD patients and 749 controls were included in this meta-analysis. The meta-analysis revealed a significantly higher cerebrospinal fluid (CSF) Se level in PD patients than those in controls (SMD = 1.22; 95%CI [0.05, 2.39]; p = 0.000). No publication bias was found.Conclusion: The meta-analysis indicated that CSF Se levels in PD patients were significantly higher than those in controls.


Subject(s)
Parkinson Disease/blood , Parkinson Disease/cerebrospinal fluid , Selenium/blood , Selenium/cerebrospinal fluid , Trace Elements/blood , Trace Elements/cerebrospinal fluid , Antioxidants/metabolism , Biomarkers/blood , Biomarkers/cerebrospinal fluid , Humans , Parkinson Disease/diagnosis
3.
Metallomics ; 12(5): 668-681, 2020 05 27.
Article in English | MEDLINE | ID: mdl-32373852

ABSTRACT

Amyotrophic lateral sclerosis is a progressive neurodegenerative disease characterized by a loss of function of motor neurons. The etiology of this disorder is still largely unknown. Gene-environment interaction arises as a possible key factor in the development of amyotrophic lateral sclerosis. We assessed the levels of trace metals, copper (Cu), iron (Fe), and manganese (Mn), of 9 amyotrophic lateral sclerosis cases and 40 controls by measuring their content in cerebrospinal fluid. The following trace element species were quantified using ion chromatography-inductively coupled plasma mass spectrometry: univalent copper (Cu-I), divalent Cu (Cu-II), divalent Fe (Fe-II), trivalent Fe (Fe-III), divalent Mn (Mn-II), trivalent Mn (Mn-III), and also unidentified Mn species (Mn-unknown) were present in some samples. When computing the relative risks for amyotrophic lateral sclerosis through an unconditional logistic regression model, we observed a weak and imprecise positive association for iron (Fe III, adjusted odds ratio 1.48, 95% CI 0.46-4.76) and manganese (total-Mn and Mn-II; adjusted odds ratio 1.11, 95% CI 0.74-1.67, and 1.13, 95% CI 0.79-1.61, respectively). Increased risk for copper was found both in the crude analysis (odds ratio 1.14, 95% CI 0.99-1.31) and in multivariable analysis after adjusting for sex, age, and year of storage (1.09, 95% CI 0.90-1.32). Our results suggest a possible positive association between Cu and genetic amyotrophic lateral sclerosis, while they give little indication of involvement of Fe and Mn in disease, though some correlations found also for these elements deserve further investigation.


Subject(s)
Amyotrophic Lateral Sclerosis/pathology , Copper/metabolism , Genetic Markers , Mutation , Trace Elements/cerebrospinal fluid , Adolescent , Adult , Amyotrophic Lateral Sclerosis/cerebrospinal fluid , Amyotrophic Lateral Sclerosis/genetics , Case-Control Studies , Child , Copper/deficiency , Female , Humans , Male , Middle Aged , Oxidation-Reduction , Young Adult
4.
Sci Rep ; 10(1): 3816, 2020 03 02.
Article in English | MEDLINE | ID: mdl-32123254

ABSTRACT

The pathogenesis of malignant brain tumors (MBTs) should be better understood due to the evident association between prolonged exposure to metals and increased risk of MBTs. The present research aimed to find trace metals that could contribute to the pathogenesis of MBTs. Essential trace elements (Mn, Co, Zn, Cu, Se) and relevant toxic metals (Al, Ni, As, Sr, Cd, Ce, Pt, Pb, U) in the serum, cell fraction (CF), cerebrospinal fluid (CSF) and cancerous tissue (CT) samples of MBT patients were analyzed. The results were compared with sex- and age-matched control groups. For the first time, this research showed that elemental profiles of serum, CF, CSF and CT samples in MBT patients were significantly altered compared to the appropriate controls, as well as that higher contents of trace elements (particularly Mn, Se, and Pb) could be involved in the pathogenesis of MBTs. However, the most noticeable change found was the elevated U content, indicating its considerable role as a major cerebral discriminator of the presence/absence of MBTs. The U/Se ratio could be considered as an appropriate blood marker in diagnostic MBT evaluation. The reported results could contribute to better understanding of the poorly understood pathogenesis of MBTs. Furthermore, the reported results could highlight a molecular basis for the pathophysiological changes caused by the hazardous effects of trace metals on brain homeostasis.


Subject(s)
Brain Neoplasms/blood , Brain Neoplasms/cerebrospinal fluid , Trace Elements/blood , Trace Elements/cerebrospinal fluid , Adult , Brain/drug effects , Brain/metabolism , Brain/pathology , Brain Neoplasms/pathology , Female , Homeostasis/drug effects , Humans , Male , Middle Aged , Trace Elements/toxicity
5.
Neuroepidemiology ; 54(1): 1-23, 2020.
Article in English | MEDLINE | ID: mdl-31454800

ABSTRACT

BACKGROUND: Parkinson's disease (PD) is the most common neurodegenerative disease after Alzheimer's dementia. Whereas the exact etiology of PD remains unknown, risk of developing PD seems to be related to a combination of genetic and environmental factors. This also includes abnormal exposure to trace elements of nutritional and toxicological interest. OBJECTIVES: In this systematic review and meta-analysis, we summarized the results of case-control studies comparing levels of selenium, copper, iron, and zinc in PD patients and controls in either blood (whole blood, serum/plasma) or cerebrospinal fluid (CSF). METHODS: We performed a systematic PubMed search selecting studies reporting trace element levels in different specimens of patients and controls. We performed a meta-analysis using a random-effect model to compute the weighted mean differences (WMD) and corresponding 95% CI of selenium, copper, iron, and zinc levels in the blood or CSF of patients and their matched controls. RESULTS: We retrieved 56 papers reporting data for selenium (cases/controls: 588/721), copper (2,190/2,522), iron (2,956/3,469), and zinc (1,798/1,913) contents in CSF and blood. Cases showed considerably higher levels of selenium in CSF compared with controls (+51.6%; WMD 5.49; 95% CI 2.82 to 8.15), while levels in serum were similar (-0.2%; WMD -0.22; 95% CI -8.05 to 7.62). For copper, cases showed slightly higher levels in CSF and slightly lower concentrations in serum (+4.5%; WMD 1.87; 95% CI -3.59 to 7.33, and -4.5%; WMD -42.79; 95% CI -134.35 to 48.76, respectively). A slight increase was also found for CSF iron -levels (+9.5%; WMD 9.92; 1.23 to 18.61), while levels were -decreased in serum/plasma (-5.7%; WMD -58.19; 95% CI -106.49 to -9.89) and whole blood (-10.8%; WMD -95.69; 95% CI -157.73 to -33.65). Conversely, for zinc cases exhibited lower levels both in CSF (-10.8%; WMD -7.34; 95% CI -14.82 to 0.14) and serum/plasma (-7.5%; WMD -79.93; 95% CI -143.80 to -16.06). A longer duration of the disease tends to be associated with overall lower trace element levels in either CSF or blood. CONCLUSIONS: Due to the study findings and the greater relevance of the CSF compartment compared with the circulating peripheral ones, this meta-analysis suggests that overexposure in the central nervous system to selenium, and possibly to copper and iron, may be a risk factor of the disease, while zinc might have a protective -effect.


Subject(s)
Parkinson Disease/etiology , Selenium , Trace Elements , Case-Control Studies , Humans , Selenium/adverse effects , Selenium/blood , Selenium/cerebrospinal fluid , Trace Elements/adverse effects , Trace Elements/blood , Trace Elements/cerebrospinal fluid
6.
Analyst ; 144(15): 4653-4660, 2019 Jul 22.
Article in English | MEDLINE | ID: mdl-31257367

ABSTRACT

In this work, we introduce a high-throughput quantitative multi-element method for biological fluids enabled by omitting sample preparation and an analysis time of a few seconds per sample. For the first time, flow injection of an undiluted cerebrospinal fluid (CSF) was combined to state-of-the-art ICP-TOFMS detection for multi-element analysis. Owing to the low sample volume and trace element concentrations of the CSF, flow injection methods with only 5 µL sample intake were used in combination with an icpTOF 2R TOF-based ICP-MS instrument. Due to the lack of certified reference materials for CSF analysis, a validated method employing open vessel digestion of the CSF material in combination with ICP-sectorfield-MS analysis was carried out and used as a reference. Additionally, the performance of the flow injection ICP-TOFMS was cross-validated by flow injection quadrupole-based ICP-MS/MS analysis using both external calibration and isotope dilution strategies. In the latter case, the sample had to be injected several times because of the need for tailored gas conditions for different elements. Overall, flow injection of biological fluids delivered quantitative values, which were in excellent agreement with the gold standard established by ICP-SFMS demonstrating the capability of ICP-TOFMS analysis in terms of resolution and sensitivity for the accurate quantification of trace elements in biological samples.


Subject(s)
Tandem Mass Spectrometry/methods , Trace Elements/cerebrospinal fluid , Animals , Calibration , Flow Injection Analysis/methods , Humans , Limit of Detection , Trace Elements/blood
7.
Neurotherapeutics ; 16(1): 192-202, 2019 01.
Article in English | MEDLINE | ID: mdl-30215171

ABSTRACT

Insufficient supply of selenium to antioxidant enzymes in the brain may contribute to Alzheimer's disease (AD) pathophysiology; therefore, oral supplementation may potentially slow neurodegeneration. We examined selenium and selenoproteins in serum and cerebrospinal fluid (CSF) from a dual-dose 24-week randomized controlled trial of sodium selenate in AD patients, to assess tolerability, and efficacy of selenate in modulating selenium concentration in the central nervous system (CNS). A pilot study of 40 AD cases was randomized to placebo, nutritional (0.32 mg sodium selenate, 3 times daily), or supranutritional (10 mg, 3 times daily) groups. We measured total selenium, selenoproteins, and inorganic selenium levels, in serum and CSF, and compared against cognitive outcomes. Supranutritional selenium supplementation was well tolerated and yielded a significant (p < 0.001) but variable (95% CI = 13.4-24.8 µg/L) increase in CSF selenium, distributed across selenoproteins and inorganic species. Reclassifying subjects as either responsive or non-responsive based on elevation in CSF selenium concentrations revealed that responsive group did not deteriorate in Mini-Mental Status Examination (MMSE) as non-responsive group (p = 0.03). Pooled analysis of all samples revealed that CSF selenium could predict change in MMSE performance (Spearman's rho = 0.403; p = 0.023). High-dose sodium selenate supplementation is well tolerated and can modulate CNS selenium concentration, although individual variation in selenium metabolism must be considered to optimize potential benefits in AD. The Vel002 study is listed on the Australian and New Zealand Clinical Trials Registry ( http://www.anzctr.org.au /), ID: ACTRN12611001200976.


Subject(s)
Alzheimer Disease/drug therapy , Antioxidants , Selenic Acid , Selenium , Trace Elements , Aged , Alzheimer Disease/blood , Alzheimer Disease/cerebrospinal fluid , Antioxidants/administration & dosage , Antioxidants/metabolism , Central Nervous System/drug effects , Central Nervous System/metabolism , Dietary Supplements , Double-Blind Method , Female , Humans , Male , Middle Aged , Pilot Projects , Selenic Acid/administration & dosage , Selenic Acid/blood , Selenic Acid/cerebrospinal fluid , Selenium/administration & dosage , Selenium/blood , Selenium/cerebrospinal fluid , Trace Elements/administration & dosage , Trace Elements/blood , Trace Elements/cerebrospinal fluid
8.
Sci Rep ; 6: 35097, 2016 10 18.
Article in English | MEDLINE | ID: mdl-27752066

ABSTRACT

Parkinson's disease (PD) is a neurodegenerative disease with the absence of markers for diagnosis. Several studies on PD reported the elements imbalance in biofluids as biomarkers. However, their results remained inconclusive. This study integrates metallomics, multivariate and artificial neural network (ANN) to understand element variations in CSF and serum of PD patients from the largest cohort of Indian population to solve the inconsistent results of previous studies. Also, this study is aimed to (1) ascertain a common element signature between CSF and serum. (2) Assess cross sectional element variation with clinical symptoms. (3) Develop ANN models for rapid diagnosis. A metallomic profile of 110 CSF and 530 serum samples showed significant variations in 10 elements of CSF and six in serum of patients compared to controls. Consistent variations in elements pattern were noticed for Calcium, Magnesium and Iron in both the fluids of PD, which provides feasible diagnosis from serum. Furthermore, implementing multivariate analyses showed clear classification between normal and PD in both the fluids. Also, ANN provides 99% accuracy in detection of disease from CSF and serum. Overall, our analyses demonstrate that elements profile in biofluids of PD will be useful in development of diagnostic markers for PD.


Subject(s)
Calcium/blood , Calcium/cerebrospinal fluid , Iron/blood , Iron/cerebrospinal fluid , Magnesium/blood , Magnesium/cerebrospinal fluid , Parkinson Disease/diagnosis , Biomarkers/blood , Biomarkers/cerebrospinal fluid , Cross-Sectional Studies , Female , Humans , India , Male , Middle Aged , Multivariate Analysis , Parkinson Disease/blood , Parkinson Disease/cerebrospinal fluid , Parkinson Disease/drug therapy , Spectrophotometry, Atomic , Trace Elements/blood , Trace Elements/cerebrospinal fluid
9.
J Trace Elem Med Biol ; 37: 1-7, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27473826

ABSTRACT

Neuropathic pain affects 1-10% of the general population and is caused by a lesion or disease of the somatosensory nervous system. Spinal cord stimulation (SCS), a method where implanted electrodes stimulate the spinal cord, has been successfully used to treat drug-resistant neuropathic pain, but the mechanism of action is largely unknown. Studies show that SCS changes the protein levels in CSF (cerebrospinal fluid) of pain patients. Several neurological conditions have been shown to alter the elemental composition of CSF. Therefore changes in the levels of ions and trace elements in the CSF may correspond to SCS use. This study used ICP-MS (Inductively coupled plasma mass spectrometry) and ICP-AES (Inductively coupled plasma atomic emission spectroscopy) to quantify 10 elements in CSF from chronic neuropathic pain patients using SCS. The element concentrations in CSF from patients with SCS treatment on/off, were measured. No effect on the element concentrations in CSF from treatment with SCS could be detected. Also, the elemental concentrations in pooled CSF from patients without chronic neuropathic pain was determined and compared to the patients using SCS. The concentration of the elements Ca, Sr, Na, K, P, Mg and Ti were, significantly higher in patients compared to the CSF-control.


Subject(s)
Chronic Pain/cerebrospinal fluid , Spinal Cord Stimulation , Trace Elements/cerebrospinal fluid , Adolescent , Adult , Aged , Female , Humans , Male , Mass Spectrometry , Middle Aged , Spectrophotometry, Atomic , Young Adult
10.
Toxicol Sci ; 150(2): 292-300, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26721301

ABSTRACT

An essential metal hypothesis for neurodegenerative disease suggests an alteration in metal homeostasis contributing to the onset and progression of disease. Similar associations have been proposed for nonessential metals. To examine the relationship between metal levels in brain tissue and ventricular fluid (VF), postmortem samples of frontal cortex (FC) and VF from Alzheimer's disease (AD) cases and nondemented elderly subjects were analyzed for arsenic (As), cadmium (Cd), chromium (Cr), cobalt (Co), copper (Cu), iron (Fe), lead (Pb), manganese (Mn), mercury (Hg), nickel (Ni), tin (Sn), vanadium (V), and zinc (Zn) using inductively coupled plasma sector field mass spectrometry. All metals, with exception of equivalent Pb levels, were lower in the VF, compared to FC. Within-subject comparisons demonstrated that VF levels were not representative of levels within brain tissue. The essential metals Cu, Fe, and Zn were found highest in both compartments. Cd, Hg, and V levels in the VF were below the limit of quantification. In AD cases, FC levels of Fe were higher and As and Cd were lower than levels in controls, while levels of As in the VF were higher. Parameter estimates for FC metal levels indicated an association of Braak stage and higher Fe levels and an association of Braak stage and lower As, Mn, and Zn levels. The data showed no evidence of an accumulation of nonessential metals within the AD brain and, with the exception of As, showed no significant shift in the ratio of FC to VF levels to indicate differential clearance.


Subject(s)
Alzheimer Disease/cerebrospinal fluid , Alzheimer Disease/metabolism , Brain/metabolism , Metals, Heavy , Trace Elements , Aged , Aged, 80 and over , Alzheimer Disease/pathology , Autopsy , Brain/pathology , Case-Control Studies , Female , Humans , Male , Metals, Heavy/cerebrospinal fluid , Metals, Heavy/metabolism , Trace Elements/cerebrospinal fluid , Trace Elements/metabolism
11.
J Trace Elem Med Biol ; 25 Suppl 1: S45-9, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21146970

ABSTRACT

The aim of this study is to analyze the variation of the elements (Ca, Mg, Cu, Fe, Zn and Mn) in normal and pathological CSF and develop a classification basing on the increases in cells and proteins and taking into account these variations. A total of 173 cerebrospinal fluids were analyzed. Of these, 37 fulfilled the criteria of normality and, after clinical exploration, were considered to be healthy (control group). The remaining 136 CSFs (pathological group) belonged to people for whom some neurological pathology had been observed in the clinical exploration and whose CSF analysis presented some abnormality. CSF was extracted by puncture in the lumbar cistern. The analysis of metals was performed by atomic absorption spectrophotometry. The statistical values (mean±standard deviation) obtained for each element analyzed in control group were as follows: Ca (mg/dL): 4.95±0.70; Mg (mg/dL): 2.74±0.10; Cu (µg/dL): 15.70±13.50; Fe (µg/dL): 13.10±3.60; Zn (µg/dL): 17.40±9.50 and Mn (µg/dL): 2.50±0.70. In the pathological CSFs, significant increases were found (p<0.050) in relation to the control group for Ca, Cu, Fe, Zn and Mn in groups with an increase of both cells and proteins. A significant decrease of Mg (p<0.050) was found in the groups with cell and protein increases. Given the results obtained in the different subgroups of the proposed classification, we conclude that it is necessary to further categorize the patients' diagnostics in the different subgroups. This would help to validate the classification.


Subject(s)
Calcium/cerebrospinal fluid , Magnesium/cerebrospinal fluid , Trace Elements/cerebrospinal fluid , Adult , Aged , Case-Control Studies , Copper/cerebrospinal fluid , Female , Humans , Iron/cerebrospinal fluid , Male , Manganese/cerebrospinal fluid , Middle Aged , Zinc/cerebrospinal fluid
12.
J Neurol Sci ; 266(1-2): 70-8, 2008 Mar 15.
Article in English | MEDLINE | ID: mdl-17900623

ABSTRACT

A hereditary neurological disease in a family in Norway has been reported recently. The disease, which we refer to as Skogholt's disease, is a demyelinating disorder of both the central and the peripheral nervous system with adult onset. We investigated whether changes in trace element concentrations could play a role in Skogholt's disease. Using high resolution inductively coupled plasma mass spectrometry, we determined 31 elements in cerebrospinal fluid (CSF), blood plasma and whole blood from these patients, multiple sclerosis patients and a control group. More than threefold increased levels of Cu and Fe, and a twofold increase in Zn were found in the CSF of Skogholt patients compared to controls. Several other significant differences in trace element levels were also found. The increased levels of Cu and Fe in CSF may indicate an active role of these metals in the pathogenesis of Skogholt's disease. Apparently, these metal ions are transferred into the CSF through their protein chelation, as raised protein levels were also seen. We suggest that redistribution of metals from transport proteins into vulnerable sites in the central (and peripheral) nervous system may initiate critical lesions.


Subject(s)
Demyelinating Diseases/blood , Demyelinating Diseases/cerebrospinal fluid , Trace Elements/blood , Trace Elements/cerebrospinal fluid , Adult , Blood Protein Electrophoresis , Female , Humans , Male , Mass Spectrometry , Middle Aged , Multiple Sclerosis/blood , Multiple Sclerosis/cerebrospinal fluid , Quality Control , Reference Standards , Syndrome
13.
Brain Res ; 1174: 136-42, 2007 Oct 12.
Article in English | MEDLINE | ID: mdl-17868660

ABSTRACT

A method to study the protein binding patterns of trace elements in human cerebrospinal fluid (CSF) is described. Proteins in CSF samples were separated by size exclusion chromatography combined with high performance liquid chromatography (SEC-HPLC). The column was calibrated to separate proteins in the molecular weight range 6-70 kDa. Fractions were then analyzed off-line for trace elements using high resolution inductively coupled plasma mass spectrometry (HR-ICP-MS). We were able to accurately determine more than 10 elements of clinical interest in the CSF fractions. Results are presented for Cd, Mn, Fe, Pb, Cu and Zn. The total concentrations of 16 trace elements in human plasma and CSF are also presented. The method was able to differentiate the relative contribution of metallothionein and other proteins towards metal binding in human CSF.


Subject(s)
Chromatography, High Pressure Liquid/methods , Chromatography, High Pressure Liquid/standards , Metallothionein/cerebrospinal fluid , Trace Elements/cerebrospinal fluid , Adult , Cadmium/cerebrospinal fluid , Calibration , Copper/cerebrospinal fluid , Female , Humans , Iron/cerebrospinal fluid , Lead/cerebrospinal fluid , Male , Manganese/cerebrospinal fluid , Metallothionein/chemistry , Middle Aged , Molecular Weight , Particle Size , Quality Control , Reproducibility of Results , Zinc/cerebrospinal fluid
14.
Guang Pu Xue Yu Guang Pu Fen Xi ; 26(4): 720-2, 2006 Apr.
Article in Chinese | MEDLINE | ID: mdl-16836148

ABSTRACT

The contents of some trace elements such as zinc, copper, iron and cadmium in cerebrospinal fluid (CSF) of normal persons and the patients who suffered cerebral hemorrhage or infarction were determined directly by atomic absorption spectrometry. The method is simple and convenient with a recovery ratio by standard addition being 97.6% to 104.8%, and a relative standard deviation (RSD) is lower than 5%. The test showed that except for the content copper lower than normal, the patients suffering cerebrovascular disease have much higher contents of zinc, iron and cadmium. The result provides useful data for studying the relation between the contents of these trace elements and cerebrovascular disease, as well as diagnosing, treating and preventing this disease.


Subject(s)
Cerebrovascular Disorders/cerebrospinal fluid , Spectrophotometry, Atomic/methods , Trace Elements/cerebrospinal fluid , Adult , Aged , Cadmium/analysis , Cerebrovascular Disorders/diagnosis , Copper/cerebrospinal fluid , Female , Humans , Iron/cerebrospinal fluid , Male , Middle Aged , Zinc/cerebrospinal fluid
15.
J Neural Transm (Vienna) ; 111(8): 1031-40, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15254791

ABSTRACT

Quantifications of Al, Ca, Cu, Fe, Mg, Mn, Si and Zn were performed in urine, serum, blood and cerebrospinal fluid (CSF) of 26 patients affected by Parkinson's disease (PD) and 13 age-matched controls to ascertain the potential role of biological fluids as markers for this pathology. Analyses were performed by Inductively Coupled Plasma Atomic Emission Spectrometry and Sector Field Inductively Coupled Plasma Mass Spectrometry. The serum oxidant status (SOS) and anti-oxidant capacity (SAC) were also determined. Results showed a decreasing trend for Al in all the fluids of PD patients, with the strongest evidence in serum. Calcium levels in urine, serum and blood of PD patients were significantly higher than in controls. Copper and Mg concentrations were significantly lower in serum of PD patients. Levels of Fe in urine, blood and CSF of patients and controls were dissimilar, with an increase in the first two matrices and a decrease in CSF. No significant difference was found in levels of Mn between patients and controls. Urinary excretion of Si was significantly higher in PD subjects than in controls. No clear difference between Zn levels in the two groups was found for serum, urine or CSF, but an increase in Zn levels in the blood of PD patients was observed. The SOS level in PD was significantly higher while the corresponding SAC was found to be lower in patients than in controls, in line with the hypothesis that oxidative damage is a key factor in the pathogenesis of PD. The results on the whole indicate the involvement of Fe and Zn (increased concentration in blood) as well as of Cu (decreased serum level) in PD. The augmented levels of Ca and Mg in the fluids and of Si in urine of patients may suggest an involuntary intake of these elements during therapy.


Subject(s)
Metals/metabolism , Parkinson Disease/metabolism , Trace Elements/metabolism , Aged , Biomarkers , Female , Humans , Male , Mass Spectrometry , Metals/blood , Metals/cerebrospinal fluid , Middle Aged , Oxidation-Reduction , Parkinson Disease/blood , Parkinson Disease/cerebrospinal fluid , Reference Values , Spectrophotometry, Atomic , Trace Elements/blood , Trace Elements/cerebrospinal fluid
18.
Bioelectromagnetics ; 20(6): 358-64, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10453063

ABSTRACT

Eight multiparous, nonlactating pregnant Holstein cows (at 198 +/- 35 days of gestation and weighing 608 + 24 kg) and seven nonlactating nonpregnant ovariectomized heifers (weighing 370 + 29 kg) were confined to wooden metabolism crates in an electric and magnetic field chamber. Subarachnoidal catheters were inserted before the activation of the electric and magnetic fields. For 30 days, cows and heifers were continuously exposed in separate trials to electric and magnetic fields (60 Hz, 10 kV/m, and 30 microT). Blood plasma and cerebrospinal fluid samples were collected for 3 consecutive days before the exposure period, the last 3 days of the exposure period, and for 3 days starting 5 days after the exposure period. Concentrations of Ca, Mg, Cu, Zn, Fe, Mn, Na, P, and K in blood plasma and cerebrospinal fluid were determined. Exposure to electric and magnetic fields resulted in decreased concentrations of Mg in blood plasma and in increased concentrations of Ca and P and decreased concentrations of Fe and Mn in cerebrospinal fluid.


Subject(s)
Cattle/blood , Cattle/cerebrospinal fluid , Electromagnetic Fields/adverse effects , Trace Elements/blood , Trace Elements/cerebrospinal fluid , Animals , Calcium/blood , Calcium/cerebrospinal fluid , Female , Iron/blood , Iron/cerebrospinal fluid , Magnesium/blood , Magnesium/cerebrospinal fluid , Manganese/blood , Manganese/cerebrospinal fluid , Phosphorus/blood , Phosphorus/cerebrospinal fluid , Pregnancy
19.
J Neural Transm (Vienna) ; 105(4-5): 479-88, 1998.
Article in English | MEDLINE | ID: mdl-9720975

ABSTRACT

We compared CSF and serum levels of iron, copper, manganese, and zinc, measured by atomic absorption spectrophotometry, in 26 patients patients with Alzheimer's disease (AD) without major clinical signs of undernutrition, and 28 matched controls. CSF zinc levels were significantly decreased in AD patients as compared with controls (p < 0.05). The serum levels of zinc, and the CSF and serum levels of iron, copper, and manganese, did not differ significantly between AD-patient and control groups. These values were not correlated with age, age at onset, duration of the disease, and scores of the MiniMental State Examination in the AD group. Weight and body mass index were significantly lower in AD patients than in controls. Because serum zinc levels were normal, the possibility that low CSF zinc levels were due to a deficiency of dietary intake seems unlikely. However, it is possible that they might be related to the interaction of beta-amyloid and/or amyloid precursor protein with zinc, that could result in a depletion of zinc levels.


Subject(s)
Alzheimer Disease/cerebrospinal fluid , Metals, Heavy/cerebrospinal fluid , Trace Elements/cerebrospinal fluid , Aged , Alzheimer Disease/blood , Blood Proteins/analysis , Copper/blood , Copper/cerebrospinal fluid , Female , Humans , Iron/blood , Iron/cerebrospinal fluid , Male , Manganese/blood , Manganese/cerebrospinal fluid , Metals, Heavy/blood , Nutritional Status , Reference Values , Spectrophotometry, Atomic/methods , Trace Elements/blood , Vitamin A/blood , Zinc/blood , Zinc/cerebrospinal fluid
20.
J Neural Transm (Vienna) ; 105(4-5): 497-505, 1998.
Article in English | MEDLINE | ID: mdl-9720977

ABSTRACT

We compared CSF and serum levels of iron, copper, manganese, and zinc, measured by atomic absorption spectrophotometry, in 37 patients with Parkinson's disease (PD) and 37 matched controls. The CSF levels of zinc were significantly decreased in PD patients as compared with controls (p < 0.05). The serum levels of zinc, and the CSF and serum levels of iron, copper, and manganese, did not differ significantly between PD-patient and control groups. There was no influence of antiparkinsonian therapy on CSF levels of none of these transition metals. These values were not correlated with age, age at onset, duration of the disease, scores of the Unified Parkinson Disease Rating Scale of the Hoehn and Yahr staging in the PD group, with the exception of CSF copper levels with the duration of the disease (r = 0.38, p < 0.05). These results suggest that low CSF zinc concentrations might be related with the risk for PD, although they could be related with oxidative stress processes.


Subject(s)
Antiparkinson Agents/therapeutic use , Metals, Heavy/cerebrospinal fluid , Parkinson Disease/cerebrospinal fluid , Trace Elements/cerebrospinal fluid , Age of Onset , Aged , Blood Proteins/analysis , Copper/blood , Copper/cerebrospinal fluid , Dopamine Agonists/therapeutic use , Female , Humans , Iron/blood , Iron/cerebrospinal fluid , Levodopa/therapeutic use , Male , Manganese/blood , Manganese/cerebrospinal fluid , Metals, Heavy/blood , Middle Aged , Nutritional Status , Parkinson Disease/blood , Parkinson Disease/drug therapy , Reference Values , Selegiline/therapeutic use , Spectrophotometry, Atomic/methods , Trace Elements/blood , Vitamin A/blood , Zinc/blood , Zinc/cerebrospinal fluid
SELECTION OF CITATIONS
SEARCH DETAIL
...